Quectel Wireless Solutions Development/Analysis Report 2022: Key Success Factors to Maintain High Growth and Continue to Increase its Market Presence – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of the Leading Chinese IoT Module Supplier: Quectel Wireless Solutions" report has…

Development of Neoway Technology: The Leading Chinese IoT Module Supplier – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of the Leading Chinese IoT Module Supplier: Neoway Technology" report has been…

Pupil and Cushman & Wakefield Enter Strategic Agreement to Deliver Digital Property Solutions

NEW YORK & SINGAPORE--(BUSINESS WIRE)--#CRE--Pupil, a spatial data company that has created an ecosystem to…

BIO-key PortalGuard Wins 2022 Fortress Cyber Security Award in Authentication and Identity

WALL, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), an innovative…

BeiGene to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

CAMBRIDGE, Mass. & BEIJING & BASEL, Switzerland--(BUSINESS WIRE)--BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a…

Options Announce Successful Go-Live in Euronext Aruba IT3 Bergamo

LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options, the leading provider of managed trading infrastructure…

Renewable Sources Now Supplying Over 20% of Promega Global Electricity Use

2022 Promega Corporate Responsibility Report shows investments in solar arrays led to ten-fold increase in…

Uptime Institute’s 2022 Outage Analysis Finds Downtime Costs and Consequences Worsening as Industry Efforts to Curb Outage Frequency Fall Short

New research details latest digital infrastructure failure rates, increasing outage costs and impacts, top downtime…

Grab to Be Fully Powered by Its Own Mapping Technology by Q3 2022

Launches GrabMaps as a new enterprise service, giving businesses the opportunity to leverage the same…

Atom Bioscience to Update Clinical Development of New Drug to Treat Gout at BIO International Convention, June 13 – 16, 2022, San Diego, CA

Phase 2a results show the orally administered ABP-671 significantly reduced uric acid levels without adverse…